Search alternatives:
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
wt decrease » _ decrease (Expand Search), nn decrease (Expand Search), awd decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
wt decrease » _ decrease (Expand Search), nn decrease (Expand Search), awd decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
14641
Figure 1 raw data
Published 2020“…We constructed a model of the minimal Rab5 activation network based on the known literature (9–11, 21, 53). …”
-
14642
-
14643
Data Sheet 5_Beyond salt tolerance: SOS1-13’s pivotal role in regulating the immune response to Fusarium oxysporum in Solanum phureja.docx
Published 2025“…</p>Results<p>StSOS1-13-overexpressed Arabidopsis differed from WT plants in multiple aspects post-FOX infection. …”
-
14644
-
14645
-
14646
-
14647
A new method of recording from the giant fiber of <i>Drosophila melanogaster</i> shows that the strength of its auditory inputs remains constant with age
Published 2020“…Subsequently JON sensitivity decreased with age, being approximately half as sensitive at 20 d and one-third as sensitive at 50 d, as compared to 10 d. …”
-
14648
-
14649
Table5_A-Kinase Anchor Protein 1 deficiency causes mitochondrial dysfunction in mouse model of hyperoxia induced acute lung injury.xlsx
Published 2022“…Wt mice exposed to hyperoxia.</p><p>Results: Transcriptome analysis of Akap1<sup>−/−</sup> exposed to hyperoxia reveals increases in transcripts encoding electron transport chain (ETC) and tricarboxylic acid cycle (TCA) proteins. …”
-
14650
-
14651
Presentation 1_Case Report: Full recovery in severe ParvovirusB19 myocarditis with DCM phenotype: the impact of rASD and PAB.pptx
Published 2025“…The pressure gradient across the PAB ranged from 40 to 45 mmHg, and LVEDD decreased to a mean z-score of +3.5. Within three to six months, LVEDD normalized, and LV-EF increased to a mean of 63% (range: 57%–68%). …”
-
14652
RecA data.
Published 2017“…The steady state rate of creation of the fluorescence is plotted on the y-axis in relative fluorescence units (RFU). The addition of a RecA inhibitor decreases the rate of production of RFUs in a concentration dependent manner. 6-Hydroxydopamine inhibits RecA with an IC<sub>50</sub> of 23 uM. …”
-
14653
Data_Sheet_1_Independent effect of body mass index variation on amyloid-β positivity.docx
Published 2022“…</p>Methods<p>We retrospectively recruited 1,035 non-demented participants ≥50 years of age who underwent Aβ PET and had at least three BMI measurements in the memory clinic at Samsung Medical Center. …”
-
14654
-
14655
-
14656
Foxf1 promotes expression of a Wnt signaling reporter.
Published 2024“…<i>Xla-Sia</i>:<i>GFP</i> embryos at 34 hpf. (<b>A’-C’</b>) <i>7xTcf</i>.<i>Xla-Sia</i>:<i>GFP</i> (green), (<b>A”-C”</b>) Mhc (red), and (<b>A”’-C”’</b>) Amhc (blue). …”
-
14657
Functional analyses of ARHGAP11A-knockdown HCT116 human colon cancer cells.
Published 2013“…(I) <i>In vivo</i> siRNA treatment of HCT116 tumors. Control HCT116 cells (5.0×10<sup>6</sup>) were implanted into NOD/SCID mice, and 1 week later were treated with PBS (<i>black filled</i> circles), atelocollagen (<i>black filled</i> triangles), scrambled control siRNA plus atelocollagen (<i>black filled</i> squares), or two siRNAs (#1 and #2) against ARHGAP11A plus atelocollagen (<i>red open</i> circles and squares, respectively). …”
-
14658
Table_1_Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary Immunodeficiencies.do...
Published 2019“…The incidence of site reactions decreased with successive infusions.</p><p>Conclusion: The new 16.5% SCIG octanorm was shown to be efficacious in preventing infections in PIDs, and was well tolerated.…”
-
14659
Table_2_Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary Immunodeficiencies.do...
Published 2019“…The incidence of site reactions decreased with successive infusions.</p><p>Conclusion: The new 16.5% SCIG octanorm was shown to be efficacious in preventing infections in PIDs, and was well tolerated.…”
-
14660
Table_2_Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary Immunodeficiencies.do...
Published 2022“…The incidence of site reactions decreased with successive infusions.</p><p>Conclusion: The new 16.5% SCIG octanorm was shown to be efficacious in preventing infections in PIDs, and was well tolerated.…”